Clinical Research Directory
Browse clinical research sites, groups, and studies.
Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin
Sponsor: University Hospital, Bordeaux
Summary
Basal insulin is widely used in older patients with diabetes. Human insulin Neutral Protamine Hagedorn (NPH) has been proposed as basal insulin in older (75 years or older) frail and dependent patients due to its shorter action. However, no study has analysed the glycaemic profile in elderly subjects according to the basal insulin used, particularly in frail or disabled patients. The aim of this study is to measure intra-day glycaemic variability according basal insulin (human NPH or long acting analogues) in older (75 and older) frail or disabled patients with diabetes using continuous glucose monitoring system.
Key Details
Gender
All
Age Range
75 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2016-03-31
Completion Date
2019-01-28
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Interventions
Insulin
Continuous glucose monitoring system over 120-hour period.
Locations (1)
University Hospital of Bordeaux - Xavier Arnozan Hospital
Pessac, France